| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ANDREEFF DANE | President and CEO, Director, 10%+ Owner | C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN | /s/ Dane Andreeff | 03 Jul 2025 | 0001201810 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HSDT | Stock Option (Right to Buy) | Award | $0 | +52,400 | $0.000000 | 52,400 | 02 Jul 2025 | Class A Common Stock | 52,400 | $9.76 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period. |